Journals / Avrupa Bilim ve Teknoloji Dergisi / 2020 / Cilt: 0 - Sayı: 20

Investigation of Pituitary-Thyroid Axis and Thyroid Functions in Adolescent Patients with Thalassemia Major

Talasemi Majorlu Adolesan Hastalarda Hipofiz-Tiroid Aksı ve TiroidFonksiyonlarının İncelenmesi

Pages
703–711
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant positive correlation between basal TSH values and peak TSH values (r = 0.38, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:With modern treatment approaches in patients with thalassemia major, the life expectancy and quality of life of patients haveincreased, but chronic hypoxia, anemia and endocrine dysfunction related to iron accumulation continue to be seen.
📊
Key Findings & Data:In various studies,thyroid dysfunction has been reported between 4% and 29% in patients with TM.
💡
Conclusion & Impact:There was a significant positive correlation between basal TSH values and peak TSH values (r = 0.38, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

With modern treatment approaches in patients with thalassemia major, the life expectancy and quality of life of patients haveincreased, but chronic hypoxia, anemia and endocrine dysfunction related to iron accumulation continue to be seen. In various studies,thyroid dysfunction has been reported between 4% and 29% in patients with TM. In this study; Examination of thyroid gland andpituitary-thyroid axis functions in patients with a diagnosis of beta thalassemia major (β-TM) and its relationship with ferritin values,which is an indicator of body iron accumulation, were investigated. Materials and Methods: Our study was designed as a prospective and single center. Twenty-two patients aged 10 years and olderwho were followed up with a diagnosis of-TM and received regular blood transfusion were included in the study. TSH response tobasal thyroid hormones, Thyroid-Stimulating Hormone (TSH) and simultaneous Thyrotropine Releasing Hormone (TRH) stimulationwere evaluated in order to examine the demographic structure, clinical characteristics, thyroid gland and pituitary-thyroid axisfunctions of the patients. Results were compared with serum ferritin values and healthy controls. Results: Eight (36.3%) of the patients were female, the mean age was 14.03 ± 2.19 years. Total transfusion time was on average149.9 ± 38.3 months. There was a significant positive correlation between basal TSH values and peak TSH values (r = 0.38, p

Özet

Talasemi majorlu hastalarda modern tedavi yaklaşımları ile hastaların yaşam süresi uzamış, yaşam kalitesi artmıştır, ancak kronikhipoksi, anemi ve demir birikimine bağlı gelişen endokrin fonksiyon bozuklukları görülmeye devam etmektedir. Çeşitli araştırmalardaTM’lu hastalarda % 4 ila % 29 arasında tiroid fonksiyon bozukluğu bildirilmektedir. Bu çalışmada; beta talasemi major ( β-TM)tanısı ile izlenen hastalarda tiroid bezi ve hipofiz-tiroid aksı fonksiyonlarının incelenmesi ve vücut demir birikiminin bir göstergesiolan ferritin değerleri ile ilişkisi araştırılmıştır. Gereç ve Yöntem: Çalışmamız prospektif ve tek merkezli olarak tasarlandı. β-TM tanısı ile izlenen ve düzenli kan transfüzyonu alan10 yaş ve üzeri 22 olgu çalışmaya dahil edildi. Hastaların demografik yapıları, klinik özellikleri, tiroid bezi ve hipofiz-tiroid aksıfonksiyonlarının incelenmesi amacıyla, bazal tiroid hormonları, Thyroid-Stimulating Hormone (TSH) ve eş zamanlı ThyrotropineReleasing Hormone (TRH) uyarısına TSH yanıtı değerlendirildi. Sonuçlar, serum ferritin değerleri ve sağlıklı kontrollerlekarşılaştırıldı.Bulgular: Hastaların 8 (%36,3)’i kız, yaş ortalaması 14.03±2.19 yıldı. Total transfüzyon süresi ortalama 149,9±38,3 aydı. Bazal TSHdeğerleri ile pik TSH değerleri arasında (r=0,38, p

🔖

Cite This Article

PEKÜN, F., ŞAHİN, A. (2022). Investigation of Pituitary-Thyroid Axis and Thyroid Functions in Adolescent Patients with Thalassemia Major. Avrupa Bilim ve Teknoloji Dergisi, Cilt: 0 - Sayı: 20, 703–711. https://ajindex.com/articles/457910

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Origa R. (2017). β-Thalassemia. Genetics in medicine: official journal of the American College of Medical Genetics, 19(6), 609–619
  2. Soliman, A. T., Al Yafei, F., Al-Naimi, L., Almarri, N., Sabt, A., Yassin, M., & De Sanctis, V. (2013). Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years. Indian journal of endocrinology and metabolism, 17(6), 1090–1095
  3. Zervas, A., Katopodi, A., Protonotariou, A., Livadas, S., Karagiorga, M., Politis, C., & Tolis, G. (2002). Assessment of thyroid function in two hundred patients with betathalassemia major. Thyroid: official journal of the American Thyroid Association, 12(2), 151–154
  4. Chirico, V., Lacquaniti, A., Salpietro, V., Luca, N., Ferraù, V., Piraino, B., Rigoli, L., Salpietro, C., & Arrigo, T. (2013). Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy. European journal of endocrinology, 169(6), 785–793
  5. Upadya, S. H., Rukmini, M. S., Sundararajan, S., Baliga, B. S., & Kamath, N. (2018). Thyroid Function in Chronically Transfused Children with Beta Thalassemia Major: A CrossSectional Hospital Based Study. International journal of pediatrics, 2018, 9071213
  6. De Sanctis, V., Soliman, A. T., Canatan, D., Yassin, M. A., Daar, S., Elsedfy, H., Di Maio, S., Raiola, G., Corrons, J. V., & Kattamis, C. (2019). Thyroid Disorders in Homozygous β-Thalassemia: Current Knowledge, Emerging Issues and Open Problems. Mediterranean journal of hematology and infectious diseases, 11(1), e2019029
  7. Belhoul, K. M., Bakir, M. L., Saned, M. S., Kadhim, A. M., Musallam, K. M., & Taher, A. T. (2012). Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Annals of hematology, 91(7), 1107– 1114
  8. Richardson, M. E., Matthews, R. N., Alison, J. F., Menahem, S., Mitvalsky, J., Byrt, E., & Harper, R. W. (1993). Prevention of heart disease by subcutaneous desferrioxamine in patients with thalassaemia major. Australian and New Zealand journal of medicine, 23(6), 656–661
  9. DeGroot LJ. Endocrinology. In: DeGroot LJ, editor. Endocrinology. Toronto: Saunders; 1989. pp. 583– 601
  10. Magro, S., Puzzonia, P., Consarino, C., Galati, M. C., Morgione, S., Porcelli, D., Grimaldi, S., Tancrè, D., Arcuri, V., & De Santis, V. (1990). Hypothyroidism in patients with thalassemia syndromes. Acta haematologica, 84(2), 72–76
  11. Sabato, A. R., de Sanc